We updated the design of this site on September 25th. Learn more.

Trial record 1 of 2126 for: parkinson's disease[ALL-FIELDS]

Previous Study | Return to List | Next Study

Nocturnal Parkinson's Disease Symptoms Study Group

This study has been completed.

Sponsor:

ClinicalTrials.gov Identifier:

NCT01662427

First Posted: August 10, 2012

Last Update Posted: August 20, 2013

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

Roongroj Bhidayasiri, Chulalongkorn University

Purpose

To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.

Condition	Intervention
Parkinson's Disease	Other: Questionaire to assess Noctural Parkinson's Disease Symptoms


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Nocturnal Parkinson's Disease Symptoms Study Group

Resource links provided by NLM:

Genetics Home Reference related topics: Parkinson disease

MedlinePlus related topics: Parkinson's Disease

U.S. FDA Resources

Further study details as provided by Roongroj Bhidayasiri, Chulalongkorn University:

Primary Outcome Measures:

To assess Noctural Parkinson's Disease Symptoms

Secondary Outcome Measures:

To assess quality of life in Parkinson's Disease patient
To assess quality of life in caregiver of Parkinson's Disease patient


Enrollment:	300
Study Start Date:	November 2012
Study Completion Date:	August 2013
Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
Questionniare	Other: Questionaire to assess Noctural Parkinson's Disease Symptoms Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	30 Years to 90 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

Parkinson's disease patient and care givers

Criteria

Inclusion Criteria:

Idiopathic Parkinson's disease patient

Exclusion Criteria:

Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01662427

Locations


Thailand
Roongroj Bhidayasiri
Pathumwan, Bangkok, Thailand, 10330

Sponsors and Collaborators

Chulalongkorn University

More Information


Responsible Party:	Roongroj Bhidayasiri, Associate Professor, Chulalongkorn University
ClinicalTrials.gov Identifier:	NCT01662427 History of Changes
Other Study ID Numbers:	6222012
First Submitted:	August 7, 2012
First Posted:	August 10, 2012
Last Update Posted:	August 20, 2013
Last Verified:	August 2013

Keywords provided by Roongroj Bhidayasiri, Chulalongkorn University:


Quality of life Noctural Parkinson's Disease Symptoms

Additional relevant MeSH terms:


Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases	Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases

To Top